Calreticulin-STAT3 Signaling Pathway Modulates Mitochondrial Function in a Rat Model of Furazolidone-Induced Dilated Cardiomyopathy

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Zhang, Ming ^a   Wei, Jin ^a   Shan, Hu ^a   Wang, Hao ^b   Zhu, Yanhe ^a   Xue, Jiahong ^a   Lin, Lin ^a   Yan, Rui ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; CYTOCHROME C OXIDASE; FURAZOLIDONE; MESSENGER RNA; SMALL INTERFERING RNA; STAT3 PROTEIN; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DRUG EXPOSURE; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; GENE EXPRESSION; GENE SILENCING; HEART HEMODYNAMICS; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MITOCHONDRION SWELLING; MORPHOMETRICS; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE DEGENERATION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BLOTTING, WESTERN; CALRETICULIN; CARDIOMYOPATHY, DILATED; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON TRANSPORT COMPLEX IV; FURAZOLIDONE; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, HEART; MITOCHONDRIAL SWELLING; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUCCINATE DEHYDROGENASE;

RATTUS;

EID: 84879272802     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066779     Document Type: Article

References (41)

1. Jefferies JL, Towbin JA, (2010) Dilated cardiomyopathy. Lancet 375: 752-762.
2. Michalak M, Groenendyk J, Szabo E, Gold LI, Opas M, (2009) Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem J 417: 651-666.
3. Mesaeli N, Nakamura K, Zvaritch E, Dickie P, Dziak E, et al. (1999) Calreticulin is essential for cardiac development. J Cell Biol 144: 857-868.
4. Hattori K, Nakamura K, Hisatomi Y, Matsumoto S, Suzuki M, et al. (2007) Arrhythmia induced by spatiotemporal overexpression of calreticulin in the heart. Mol Genet Metab 91: 285-293.
5. Nakamura K, Robertson M, Liu G, Dickie P, Guo JQ, et al. (2001) Complete heart block and sudden death in mice overexpressing calreticulin. J Clin Invest 107: 1245-1253.
6. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, et al. (1995) Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92: 778-784.
7. Suzuki O, Kanai T, Nishikawa T, Yamamoto Y, Noguchi A, et al. (2011) Adult onset cardiac dilatation in a transgenic mouse line with Galbeta1,3GalNAc alpha2,3-sialyltransferase II (ST3Gal-II) transgenes: a new model for dilated cardiomyopathy. Proc Jpn Acad Ser B Phys Biol Sci 87: 550-562.
8. Hilfiker-Kleiner D, Hilfiker A, Drexler H, (2005) Many good reasons to have STAT3 in the heart. Pharmacol Ther 107: 131-137.
9. Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, et al. (2003) Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation 107: 798-802.
10. Kunisada K, Negoro S, Tone E, Funamoto M, Osugi T, et al. (2000) Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci U S A 97: 315-319.
11. Negoro S, Kunisada K, Fujio Y, Funamoto M, Darville MI, et al. (2001) Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation 104: 979-981.
12. Coe H, Jung J, Groenendyk J, Prins D, Michalak M, (2010) ERp57 modulates STAT3 signaling from the lumen of the endoplasmic reticulum. J Biol Chem 285: 6725-6738.
13. Du XL, Yang H, Liu SG, Luo ML, Hao JJ, et al. (2009) Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma. Oncogene 28: 3714-3722.
14. Recchia FA, Lionetti V, (2007) Animal models of dilated cardiomyopathy for translational research. Vet Res Commun 31Suppl 1: 35-41.
15. Hajjar RJ, Liao R, Young JB, Fuleihan F, Glass MG, et al. (1993) Pathophysiological and biochemical characterisation of an avian model of dilated cardiomyopathy: comparison to findings in human dilated cardiomyopathy. Cardiovasc Res 27: 2212-2221.
16. Wu Y, Tobias AH, Bell K, Barry W, Helmes M, et al. (2004) Cellular and molecular mechanisms of systolic and diastolic dysfunction in an avian model of dilated cardiomyopathy. J Mol Cell Cardiol 37: 111-119.
17. Kim CS, Davidoff AJ, Maki TM, Doye AA, Gwathmey JK, (2000) Intracellular calcium and the relationship to contractility in an avian model of heart failure. J Comp Physiol B 170: 295-306.
18. Dujardin KS, Tei C, Yeo TC, Hodge DO, Rossi A, et al. (1998) Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy. Am J Cardiol 82: 1071-1076.
19. Jensen RA, Acton EM, Peters JH, (1984) Doxorubicin cardiotoxicity in the rat: comparison of electrocardiogram, transmembrane potential, and structural effects. J Cardiovasc Pharmacol 6: 186-200.
20. Weibel ER, (1969) Stereological principles for morphometry in electron microscopic cytology. Int Rev Cytol 26: 235-302.
21. Lee KS, Park JH, Lim HJ, Park HY, (2011) HB-EGF induces cardiomyocyte hypertrophy via an ERK5-MEF2A-COX2 signaling pathway. Cell Signal 23: 1100-1109.
22. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
23. Yoo KJ, Li RK, Weisel RD, Mickle DA, Jia ZQ, et al. (2000) Heart cell transplantation improves heart function in dilated cardiomyopathic hamsters. Circulation 102: III204-209.
24. Song W, Dyer E, Stuckey D, Leung MC, Memo M, et al. (2010) Investigation of a transgenic mouse model of familial dilated cardiomyopathy. J Mol Cell Cardiol 49: 380-389.
25. Shimizu T, Nojiri H, Kawakami S, Uchiyama S, Shirasawa T, (2010) Model mice for tissue-specific deletion of the manganese superoxide dismutase gene. Geriatr Gerontol Int 10Suppl 1: S70-79.
26. Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, et al. (2005) Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112: 1128-1135.
27. Cesselli D, Jakoniuk I, Barlucchi L, Beltrami AP, Hintze TH, et al. (2001) Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 89: 279-286.
28. Toyoda Y, Okada M, Kashem MA, (1998) A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration. J Thorac Cardiovasc Surg 115: 1367-1373.
29. Goedel-Meinen L, Hofmann M, Ryba S, Schomig A (2001) Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic dilated cardiomyopathy. Am J Cardiol 87: 809-812, A809.
30. Nozynski J, Zakliczynski M, Konecka-Mrowka D, Zeglen S, Przybylski R, et al. (2009) Differences in antiapoptotic, proliferative activities and morphometry in dilated and ischemic cardiomyopathy: study of hearts explanted from transplant recipients. Transplant Proc 41: 3171-3178.
31. Deisher TA, Ginsburg R, Fowler MB, Billingham ME, Bristow MR, (1995) Spontaneous reversibility of catecholamine-induced cardiotoxicity in rats. Am J Cardiovasc Pathol 5: 79-88.
32. Powers MD, Good AL, Czarnecki CM, Evanson OA, (1983) Monoamine oxidase inhibition and furazolidone-induced cardiomyopathy in turkey poults. Poult Sci 62: 1850-1855.
33. Haghikia A, Stapel B, Hoch M, Hilfiker-Kleiner D, (2011) STAT3 and cardiac remodeling. Heart Fail Rev 16: 35-47.
34. Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, et al. (2009) Function of mitochondrial Stat3 in cellular respiration. Science 323: 793-797.
35. Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R, (2010) Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 105: 771-785.
36. Szczepanek K, Chen Q, Larner AC, Lesnefsky EJ, (2012) Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3. Mitochondrion 12: 180-189.
37. Rosca MG, Hoppel CL, (2010) Mitochondria in heart failure. Cardiovasc Res 88: 40-50.
38. Jarreta D, Orus J, Barrientos A, Miro O, Roig E, et al. (2000) Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res 45: 860-865.
39. Sam F, Kerstetter DL, Pimental DR, Mulukutla S, Tabaee A, et al. (2005) Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail 11: 473-480.
40. Lim S, Chang W, Lee BK, Song H, Hong JH, et al. (2008) Enhanced calreticulin expression promotes calcium-dependent apoptosis in postnatal cardiomyocytes. Mol Cells 25: 390-396.
41. Yu HC, Qin HY, He F, Wang L, Fu W, et al. (2011) Canonical notch pathway protects hepatocytes from ischemia/reperfusion injury in mice by repressing reactive oxygen species production through JAK2/STAT3 signaling. Hepatology 54: 979-988.